Sign in Subscribe
Cancer research

Weight-Loss Jabs Could Cut Cancer Risk by Almost Half

Strategic Insights

— 1 min read

Research suggests that weight-loss medications, such as GLP-1 receptor agonists, may reduce the risk of cancer by almost half, potentially surpassing the benefits of bariatric surgery. A study of over 6,000 obese patients with Type 2 diabetes found that those who received weight-loss medications experienced a significant reduction in cancer risk, while those who underwent bariatric surgery saw a 42% reduction. The study's findings have significant implications for the prevention and treatment of cancer, particularly in high-risk individuals.

Key Takeaways:

  • The study analyzed the health records of over 6,000 obese patients with Type 2 diabetes, who were either prescribed GLP-1 medications or underwent bariatric surgery.
  • The GLP-1 medications reduced the risk of cancer by almost half, potentially surpassing the benefits of bariatric surgery, which reduced cancer risk by 30-42%.
  • The study's findings have significant implications for the prevention and treatment of cancer, particularly in high-risk individuals.
  • Experts believe that weight-loss medications may have a more powerful mechanism than bariatric surgery in reducing cancer risk.
  • The results of the study may be even better, as newer and more effective versions of GLP-1 medications have been developed since the trial.

Statistics:

  • 40% of cancer cases in the UK are linked to obesity (Source: Britain is preparing to launch a trial of weight-loss jabs to combat soaring rates of cancer).
  • 30 types of cancer may be fueled by excess weight (Source: Britain is preparing to launch a trial of weight-loss jabs to combat soaring rates of cancer).
  • 1 in 2 people in the UK is forecast to get cancer in their lifetime (Source: Britain is preparing to launch a trial of weight-loss jabs to combat soaring rates of cancer).
  • Weight loss medications have been found to set back the clock on a host of diseases, including heart death (Source: A year ago, a study found the jabs cut the risk of heart death by a fifth).

Sources:

  • Britain is preparing to launch a trial of weight-loss jabs to combat soaring rates of cancer.
  • A year ago, a study found the jabs cut the risk of heart death by a fifth.
  • The research is published in the journal eClinicalMedicine.

Read more